|
FY2025
12 months to Dec 27, 2025
|
FY2024
12 months to Dec 28, 2024
|
FY2023
12 months to Dec 30, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 25, 2021
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of products sold | |||||
| Gross profit | |||||
| Selling, general and administrative expenses, excluding impairment losses | |||||
| Goodwill impairment losses | |||||
| Intangible asset impairment losses | |||||
| Selling, general and administrative expenses | |||||
| Operating income/(loss) | |||||
| Interest expense | |||||
| Other expense/(income) | |||||
| Income/(loss) before income taxes | |||||
| Provision for/(benefit from) income taxes | |||||
| Net income/(loss) | |||||
| Net income/(loss) attributable to noncontrolling interest | |||||
| Net income/(loss) attributable to common shareholders | |||||
| Per share data applicable to common shareholders: | |||||
| Basic earnings/(loss) per share (in dollars per share) | |||||
| Diluted earnings/(loss) per share (in dollars per share) |
Loading...
